DK149589A - Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme - Google Patents

Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme

Info

Publication number
DK149589A
DK149589A DK149589A DK149589A DK149589A DK 149589 A DK149589 A DK 149589A DK 149589 A DK149589 A DK 149589A DK 149589 A DK149589 A DK 149589A DK 149589 A DK149589 A DK 149589A
Authority
DK
Denmark
Prior art keywords
pyrazole compounds
analogy process
preparing polycyclic
polycyclic
preparing
Prior art date
Application number
DK149589A
Other languages
English (en)
Other versions
DK149589D0 (da
Inventor
Joseph Mccrary Mccune
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of DK149589D0 publication Critical patent/DK149589D0/da
Publication of DK149589A publication Critical patent/DK149589A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK149589A 1988-03-28 1989-03-28 Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme DK149589A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17400588A 1988-03-28 1988-03-28

Publications (2)

Publication Number Publication Date
DK149589D0 DK149589D0 (da) 1989-03-28
DK149589A true DK149589A (da) 1989-09-29

Family

ID=22634418

Family Applications (1)

Application Number Title Priority Date Filing Date
DK149589A DK149589A (da) 1988-03-28 1989-03-28 Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme

Country Status (5)

Country Link
EP (1) EP0335635A1 (da)
JP (1) JPH029372A (da)
AU (1) AU3170089A (da)
DK (1) DK149589A (da)
IL (1) IL89567A0 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02203783A (ja) * 1989-02-02 1990-08-13 Banyu Pharmaceut Co Ltd 抗原性を有する非感染性エイズウイルス産生クローン化ヒトｔ細胞
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
US5861282A (en) * 1989-10-16 1999-01-19 Whitehead Institute For Biomedical Research Non-infectious HIV particles and uses therefor
DE69111440T2 (de) * 1990-04-03 1996-03-28 Genentech Inc Methoden und zusammensetzungen zur impfung gegen hiv.
US7041293B1 (en) 1990-04-03 2006-05-09 Genentech, Inc. HIV env antibodies
WO1991019795A1 (en) * 1990-06-19 1991-12-26 Immuvax Nonpathogenic variant virus
KR100194079B1 (ko) * 1990-09-28 1999-06-15 장 스테판느 Hiv 감염 예방 또는 치료용 제약학적 조성물 및 이의 제조방법
GB9106048D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccines
CA2093427C (en) * 1990-10-17 2008-01-15 Marvin S. Reitz, Jr. Molecular clones of hiv-1 and uses thereof
FR2676071B1 (fr) * 1991-05-02 1994-11-18 Transgene Sa Nouveau variant gp160 non-clivable, soluble, de forme hybride.
NZ249808A (en) * 1992-03-27 1996-09-25 Int Flower Dev Pty Ltd Genetic sequence encoding flavonoid pathway enzymes and their uses
US6174666B1 (en) 1992-03-27 2001-01-16 The United States Of America As Represented By The Department Of Health And Human Services Method of eliminating inhibitory/instability regions from mRNA
GB9215233D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
WO1994016081A1 (de) * 1993-01-16 1994-07-21 Manfred Schawaller Verfahren zur gewinnung nativer domänen viraler membranproteine, deren verwendung, insbesondere als impfstoff gegen hiv
US5864027A (en) * 1993-06-07 1999-01-26 Genentech, Inc. HIV envelope polypeptides
US5795737A (en) * 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
US6114148C1 (en) * 1996-09-20 2012-05-01 Gen Hospital Corp High level expression of proteins
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
EP2388015A1 (en) * 2000-03-02 2011-11-23 Emory University DNA expression vectors and methods of use
AU2001284999B2 (en) 2000-08-14 2006-09-21 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modifications of HIV Env, Gag and Pol enhance immunogenicity for genetic immunization
DK1372710T3 (da) 2001-03-08 2010-01-18 Us Gov Health & Human Serv MVA der udtrykker modificeret HIV-kappe-, Gag- og Pol-gener
ATE458496T1 (de) * 2002-01-14 2010-03-15 Novartis Vaccines & Diagnostic Hiv-vakzine und anwendungsverfahren
US9783594B2 (en) 2011-05-17 2017-10-10 The Rockefeller University Human immunodeficiency virus neutralizing antibodies and methods of use thereof
US20150355178A1 (en) * 2012-09-04 2015-12-10 Mbio Diagnostics, Inc. System and method for improving biomarker assay

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2606029B2 (fr) * 1986-04-08 1989-02-03 Transgene Sa Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus
EP0272858A3 (en) * 1986-12-15 1989-07-12 Repligen Corporation Recombinant hiv envelope proteins produced in insect cells

Also Published As

Publication number Publication date
EP0335635A1 (en) 1989-10-04
JPH029372A (ja) 1990-01-12
DK149589D0 (da) 1989-03-28
IL89567A0 (en) 1989-09-10
AU3170089A (en) 1989-09-28

Similar Documents

Publication Publication Date Title
DK149589A (da) Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme
GB2257149B (en) Process for preparing polyoxyalkylene- or alkylpolyglucoside- carboxylates
AU8225491A (en) Process for preparing dibenzylidene-d-sorbitol compounds
HU907100D0 (en) Process for producing cephalosporine derivatives
SG48341A1 (en) Process for preparing benzopyran compounds
HUT52487A (en) Process for producing mono-n-alkyl-polyaza-makroring compounds
YU24088A (en) Process for preparing heterocyclical compounds
IL88943A0 (en) Process for preparing 1-alkyl-5-nitroimidazoles
GB2216519B (en) Process for preparing n-sulphonyl-ureas
KR960009690B1 (en) Process for preparing polyarylenethioether
HU905944D0 (en) Process for producing new macrolidic compounds
CZ70895A3 (en) Process for preparing substituted 5-formylimidazole compounds
GB8919709D0 (en) Process for preparing 2-methoxyisobutylisonitrile
EP0503294A3 (en) Process for preparing perfluorpolyetheracrylfluorides
EP0341063A3 (en) Process for preparing 5-c-hydroxymethyl aldohexose-based compounds
LTIP349A (en) Process for preparing trijodobenzene compounds
AU7471791A (en) Process for preparing hydroxyalkyl-1 nitro-5 imidazoles
LTIP847A (en) Process for preparing imidazole derivatives
PT84492A (en) Process for preparing gametocidal pyrazoles
YU81090A (en) Process for preparing polycyclical compounds
YU146589A (en) Process for preparing new alylaminoethyl-azoles
ZA925560B (en) Process for preparing 13alpha-cinnamoyl-baccatine iii or-10-deacetyl-baccatine iii
GB2223232B (en) Process for preparing sulphoxide containing compounds
IL104398A0 (en) Process for preparing substituted 2-cyanopyridines
IL103261A0 (en) Process for preparing 4-chlorobenzotrichloride

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment